West Pharmaceutical Services (WST) to pay $0.16 on Feb 5, 2020; LINAMAR ORDINARY SHARES (LIMAF) Shorts Raised By 14.67%

Linamar Corporation (OTCMKTS:LIMAF) Logo

LINAMAR CORP ORDINARY SHARES (OTCMKTS:LIMAF) had an increase of 14.67% in short interest. LIMAF’s SI was 435,400 shares in January as released by FINRA. Its up 14.67% from 379,700 shares previously. With 9,700 avg volume, 45 days are for LINAMAR CORP ORDINARY SHARES (OTCMKTS:LIMAF)’s short sellers to cover LIMAF’s short positions. The stock decreased 0.96% or $0.35 during the last trading session, reaching $35.98. About 6,300 shares traded or 0.77% up from the average. Linamar Corporation (OTCMKTS:LIMAF) has 0.00% since January 16, 2019 and is . It has by 0.00% the S&P500.

West Pharmaceutical Services Inc (NYSE:WST) is expected to pay $0.16 on Feb 5, 2020. (NYSE:WST) shareholders before Jan 21, 2020 will receive the $0.16 dividend. West Pharmaceutical Services Inc’s current price of $157.19 translates into 0.10% yield. West Pharmaceutical Services Inc’s dividend has Jan 22, 2020 as record date. Dec 13, 2019 is the announcement. The stock increased 0.45% or $0.7 during the last trading session, reaching $157.19. About 401,134 shares traded. West Pharmaceutical Services, Inc. (NYSE:WST) has risen 35.92% since January 16, 2019 and is uptrending. It has outperformed by 35.92% the S&P500. Some Historical WST News: 26/04/2018 – West Pharma 1Q EPS 58c; 26/04/2018 – WEST PHARMACEUTICAL SERVICES INC – ESTIMATES ITS 2018 CAPITAL SPENDING WILL BE LESS THAN $150 MLN; 26/04/2018 – West Pharma 1Q Net $43.6M; 26/04/2018 – WEST PHARMACEUTICAL SERVICES INC – REAFFIRMED FINANCIAL GUIDANCE FOR FULL-YEAR 2018; 30/05/2018 – West Pharma Closes Above 200-Day Moving Average: Technicals; 20/04/2018 – DJ West Pharmaceutical Services Inc, Inst Holders, 1Q 2018 (WST); 03/05/2018 – West Pharma Board Approves 4Q Dividend Increase to 15c; 09/05/2018 – USS Investment LTD. Buys New 1.2% Position in West Pharma; 07/03/2018 HEALTHPRIZE & WEST EXTEND CONNECTED HEALTH PARTNERSHIP; 19/03/2018 – West to Showcase DAIKYO PLASCAPĀ® RUV One-Step Press-Fit Vial Closure Solution at PDA Annual Meeting

West Pharmaceutical Services, Inc. manufactures and sells packaging components and delivery systems for injectable drugs and healthcare products in the United States, Germany, France, Other European countries, and internationally. The company has market cap of $11.63 billion. The company's Proprietary Products segment offers stoppers and seals for injectable packaging systems; and syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies. It has a 51.54 P/E ratio. It also provides drug containment solutions, including CZ vials, syringes, and cartridges; and self-injection systems, as well as specialized testing services for drug packaging, devices, and administration systems.

More notable recent West Pharmaceutical Services, Inc. (NYSE:WST) news were published by: Nasdaq.com which released: “Large-Cap Stocks Going Ex-Dividend Next Week – Nasdaq” on January 15, 2020, also Benzinga.com with their article: “The Daily Biotech Pulse: Osmotica Soars On Insider Buys, Ultragenyx’s Partnered Rare Disease Drug Moves Into Clinics – Benzinga” published on January 16, 2020, Finance.Yahoo.com published: “How Did West Pharmaceutical Services Inc. (WST) Compare Against Top Hedge Fund Stocks in 2019? – Yahoo Finance” on January 08, 2020. More interesting news about West Pharmaceutical Services, Inc. (NYSE:WST) were released by: Finance.Yahoo.com and their article: “The Daily Biotech Pulse: PhaseBio To Buy Hypertension Asset, Stemline Falls On Q4 Pre-Announcement, FDA Panel To Review Nektar’s Opioid Drug – Yahoo Finance” published on January 14, 2020 as well as Benzinga.com‘s news article titled: “The Daily Biotech Pulse: Nektar Withdraws Opioid Pain Drug NDA, Galapagos Takes Stake In Fibrocor, Integra Lifesciences Lowers Q4 Guidance – Benzinga” with publication date: January 15, 2020.

Investors sentiment increased to 1.38 in Q3 2019. Its up 0.13, from 1.25 in 2019Q2. It improved, as 17 investors sold West Pharmaceutical Services, Inc. shares while 103 reduced holdings. 65 funds opened positions while 101 raised stakes. 65.43 million shares or 2.12% less from 66.85 million shares in 2019Q2 were reported. Natixis Advisors L P stated it has 15,199 shares. Stifel holds 0.01% or 39,723 shares in its portfolio. Manufacturers Life Ins The invested in 0.02% or 109,458 shares. Alps Advsr, Colorado-based fund reported 2,547 shares. 1,625 are held by Bradley Foster Sargent Ct. Regions Corp holds 0% or 3,049 shares. Martingale Asset L P owns 5,105 shares. Symphony Asset Lc stated it has 1,661 shares. Meeder Asset Inc owns 1,869 shares. Qs Limited Liability has invested 0% of its portfolio in West Pharmaceutical Services, Inc. (NYSE:WST). Texas Permanent School Fund invested in 50,196 shares or 0.11% of the stock. Citadel Advisors Limited Liability Corporation invested in 0.01% or 128,461 shares. Piedmont Inv Advisors invested in 0.06% or 10,684 shares. Stonebridge Cap Advsr reported 5 shares. Wetherby Asset Mgmt Incorporated has invested 0.03% in West Pharmaceutical Services, Inc. (NYSE:WST).

More notable recent Linamar Corporation (OTCMKTS:LIMAF) news were published by: Seekingalpha.com which released: “Linamar: Diversified Manufacturer At An Attractive Price – Seeking Alpha” on October 18, 2019, also Seekingalpha.com with their article: “Linamar: A Standout Amongst Auto OEMs – Seeking Alpha” published on August 09, 2019, Seekingalpha.com published: “Linamar: Finding Value In Auto Companies – Seeking Alpha” on March 21, 2019. More interesting news about Linamar Corporation (OTCMKTS:LIMAF) were released by: Seekingalpha.com and their article: “PetroTal: An Overlooked Spin-Off – Seeking Alpha” published on December 17, 2019 as well as Seekingalpha.com‘s news article titled: “New NAFTA Linamar DCF Valuation – Seeking Alpha” with publication date: November 06, 2018.

West Pharmaceutical Services, Inc. (NYSE:WST) Institutional Positions Chart